Skip to main content
. 2023 Apr 3;78(10):983–989. doi: 10.1136/thorax-2022-219382

Figure 2.

Figure 2

Comparison of annual exacerbation rate between the treated (fluticasone furoate/vilanterol, FF/VI) and untreated (placebo) subjects in the test set in SUMMIT per each quantile in the five quantile discretisation. Negative binomial analysis was used to compare the subjects per quantile. SUMMIT, Study to Understand Mortality and Morbidity in COPD.